Effect of DOAC-Remove on coagulation screening assays in samples from patients receiving oral or parenteral anticoagulation

Int J Lab Hematol. 2022 Jun;44(3):e95-e99. doi: 10.1111/ijlh.13743. Epub 2021 Oct 28.

Authors

Zahra Al-Qawzai^{1

2}, Chris Dale^{1

3}, Minal Dave^{1

3}, Nada Yartey^{1

3}, Sean Platton^{1

4}

Affiliations

¹ NHS East and South East London Pathology Partnership, The Royal London Hospital, Barts Health NHS Trust, London, UK.
² Clinical Biochemistry Laboratory, The Royal London Hospital, Barts Health NHS Trust, London, UK.
³ Haemostasis Laboratory, The Royal London Hospital, Barts Health NHS Trust, London, UK.
⁴ The Royal London Hospital Haemophilia Centre, The Royal London Hospital, Barts Health NHS Trust, London, UK.

PMID: 34708545
DOI: 10.1111/ijlh.13743

No abstract available

Publication types

Letter

MeSH terms

Administration, Oral
Anticoagulants* / pharmacology
Anticoagulants* / therapeutic use
Blood Coagulation Tests
Blood Coagulation*
Humans

Substances

Anticoagulants